These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 18223228)

  • 1. Rhabdoid tumor growth is inhibited by flavopiridol.
    Smith ME; Cimica V; Chinni S; Challagulla K; Mani S; Kalpana GV
    Clin Cancer Res; 2008 Jan; 14(2):523-32. PubMed ID: 18223228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases.
    Raju U; Ariga H; Koto M; Lu X; Pickett J; Valdecanas D; Mason KA; Milas L
    Radiother Oncol; 2006 Aug; 80(2):185-91. PubMed ID: 16905211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cyclin-dependent kinase inhibitor flavopiridol potentiates gamma-irradiation-induced apoptosis in colon and gastric cancer cells.
    Jung C; Motwani M; Kortmansky J; Sirotnak FM; She Y; Gonen M; Haimovitz-Friedman A; Schwartz GK
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6052-61. PubMed ID: 14676132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of apoptosis and down regulation of cell cycle proteins in mantle cell lymphoma by flavopiridol treatment.
    Venkataraman G; Maududi T; Ozpuyan F; Bahar HI; Izban KF; Qin JZ; Alkan S
    Leuk Res; 2006 Nov; 30(11):1377-84. PubMed ID: 16624404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic effect of flavopiridol, a small molecular cyclin-dependent kinase inhibitor, in human ovarian carcinoma].
    Song Y; Shen K; Tang PP
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):761-4. PubMed ID: 18307904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flavopiridol, an inhibitor of cyclin-dependent kinases, induces growth inhibition and apoptosis in bladder cancer cells in vitro and in vivo.
    Wirger A; Perabo FG; Burgemeister S; Haase L; Schmidt DH; Doehn C; Mueller SC; Jocham D
    Anticancer Res; 2005; 25(6B):4341-7. PubMed ID: 16309238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
    Miyashita K; Shiraki K; Fuke H; Inoue T; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
    Int J Mol Med; 2006 Aug; 18(2):249-56. PubMed ID: 16820931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis.
    Patel V; Senderowicz AM; Pinto D; Igishi T; Raffeld M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS
    J Clin Invest; 1998 Nov; 102(9):1674-81. PubMed ID: 9802881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutically targeting cyclin D1 in primary tumors arising from loss of Ini1.
    Smith ME; Cimica V; Chinni S; Jana S; Koba W; Yang Z; Fine E; Zagzag D; Montagna C; Kalpana GV
    Proc Natl Acad Sci U S A; 2011 Jan; 108(1):319-24. PubMed ID: 21173237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibition and induction of apoptosis by flavopiridol in rat lung adenocarcinoma, osteosarcoma and malignant fibrous histiocytoma cell lines.
    Honoki K; Yoshitani K; Tsujiuchi T; Mori T; Tsutsumi M; Morishita T; Takakura Y; Mii Y
    Oncol Rep; 2004 May; 11(5):1025-30. PubMed ID: 15069542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
    Bearss DJ; Lee RJ; Troyer DA; Pestell RG; Windle JJ
    Cancer Res; 2002 Apr; 62(7):2077-84. PubMed ID: 11929828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors.
    Alarcon-Vargas D; Zhang Z; Agarwal B; Challagulla K; Mani S; Kalpana GV
    Oncogene; 2006 Feb; 25(5):722-34. PubMed ID: 16302003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells.
    Raju U; Nakata E; Mason KA; Ang KK; Milas L
    Cancer Res; 2003 Jun; 63(12):3263-7. PubMed ID: 12810657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model.
    Ishii Y; Pirkmaier A; Alvarez JV; Frank DA; Keselman I; Logothetis D; Mandeli J; O'Connell MJ; Waxman S; Germain D
    J Natl Cancer Inst; 2006 Sep; 98(17):1238-47. PubMed ID: 16954476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin disrupts cyclin/cyclin-dependent kinase/p21/proliferating cell nuclear antigen complexes and cyclin D1 reverses rapamycin action by stabilizing these complexes.
    Law M; Forrester E; Chytil A; Corsino P; Green G; Davis B; Rowe T; Law B
    Cancer Res; 2006 Jan; 66(2):1070-80. PubMed ID: 16424043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic analysis of the antiproliferative effects of novel and standard anticancer agents in rhabdoid tumor cell lines.
    Lünenbürger H; Lanvers-Kaminsky C; Lechtape B; Frühwald MC
    Anticancer Drugs; 2010 Jun; 21(5):514-22. PubMed ID: 20147838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in multiple myeloma cells through transcriptional repression and down-regulation of Mcl-1.
    Gojo I; Zhang B; Fenton RG
    Clin Cancer Res; 2002 Nov; 8(11):3527-38. PubMed ID: 12429644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavopiridol induces cell cycle arrest and p53-independent apoptosis in non-small cell lung cancer cell lines.
    Shapiro GI; Koestner DA; Matranga CB; Rollins BJ
    Clin Cancer Res; 1999 Oct; 5(10):2925-38. PubMed ID: 10537362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent inhibition of rhabdoid tumor cells by combination of flavopiridol and 4OH-tamoxifen.
    Cimica V; Smith ME; Zhang Z; Mathur D; Mani S; Kalpana GV
    BMC Cancer; 2010 Nov; 10():634. PubMed ID: 21092078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.
    Schwartz GK; Farsi K; Maslak P; Kelsen DP; Spriggs D
    Clin Cancer Res; 1997 Sep; 3(9):1467-72. PubMed ID: 9815832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.